Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. (Q63397428)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. |
clinical trial |
Statements
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome. (English)
0 references
1 January 2018
0 references
30 June 2019
0 references
108
0 references